translating tolerogenic therapies to the clinic ā where do we stand?
Clicks: 173
ID: 224834
2012
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.3
/100
1 views
1 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Manipulation of the immune system to prevent the development of a specific immune response is an ideal strategy to improve outcomes after transplantation. A number of experimental techniques exploiting central and peripheral tolerance mechanisms have demonstrated success, leading to the first early phase clinical trials for tolerance induction. The first major strategy centres on the facilitation of donor-cell mixed chimerism in the transplant recipient with the use of bone marrow or haematopoietic stem cell transplantation. The second strategy, utilising peripheral regulatory mechanisms, focuses on cellular therapy with regulatory T cells. This review examines the key studies and novel research directions in the field of immunological tolerance.| Reference Key |
eissa2012frontierstranslating
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Fadi eIssa;Kathryn J. Wood |
| Journal | sudebno-meditsinskaia ekspertiza |
| Year | 2012 |
| DOI | 10.3389/fimmu.2012.00254 |
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.